Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Keneng Chen
Peking University Cancer Hospital & Institute
Principal Investigator - Lin Shen
Peking University Cancer Hospital & Institute
Principal Investigator - Yan Zheng
Henan Cancer Hospital
Principal Investigator - Yongtao Han
Sichuan Cancer Hospital and Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Firest Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
- Anhui Provincial Hospital
Hefei, Anhui, China
- the Second Hospital of Anhui Medical University
Hefei, Anhui, China
- Jiangmen Central Hospital
Jiangmen, Guangdong, China
- Shenzhen People'S Hosptial
Shenzhen, Guangdong, China
- the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- Anyang Cancer Hospital
Anyang, Henan, China
- the First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
- Henan Provincial Pepples Hospital
Zhengzhou, Henan, China
- the First Affilated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Hunan Provincial Cancer Hospital
Changsha, Hunan, China
- China-Japan Union Hosptial of Jilin University
Changchun, Jilin, China
- the First Affiliated Hospital of Jinzhou Medical University
Jinzhou, Niaoning, China
- Shanxi Provincial Cancer Hosptial
Taiyuan, Shanxi, China
- Affiliated Tumor Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
- Hwa Mei Hospital,university of Chinese Academy of Sciences
Ningbo, Zhejiang, China
- Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
- Beijing Cancer Hospital
Beijing, China
- Peking University Third Hospital
Beijing, China
- the General Hospital of People'S Liberation Army
Beijing, China
- Heping Hospital Affiliated To Changzhi Medical College
Changzhi, China
- Sichuan Cancer Hospital & Institute
Chengdu, China
- Fujian Cancer Hospital
Fuzhou, China
- 3201 Hospital
Hangzhou, China
- Zhejiang Cancer Hospital
Hangzhou, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Hanzhou, China
- Harbin Medical University Cancer Hospital
Harbin, China
- Anhui Provincial Cancer Hospital
Hefei, China
- Huai'An First People'S Hospital
Huai'an, China
- the Affiliated Hospital of Jining Medical University
Jining, China
- the First Affiliated Hospital of Nanchang University
Nanchang, China
- Jiangsu Cancer Hospital
Nanjing, China
- the Affiliated Hospital of Qingdao University
Qingdao, China
- Zhongshan Hospital Fudan University
Shanghai, China
- Shantou University Cancer Hospital
Shantou, China
- Liaoning Cancer Hospital& Institute
Shenyang, China
- Shengjing Hospital of China Medical University
Shenyang, China
- the First Hospital of China Medical University
Shenyang, China
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
- Hubei Cancer Hospital
Wuhan, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 May 2021
- Primary completion
- 12 May 2027
- Completion
- 12 May 2027
- Last update posted
- 8 Apr 2026
- Registered enrollment
- 663
- Registry id
- NCT04848753
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.